OXBOF Company Profile and Key Details

Q: Who are the executives of OXBOF?

Mr. Paul Leslie Stockdale F.C.A., M.A.Chief Financial Officer & Executive DirectorDr. Alexandre Akoulitchev M.A., Ma (Oxon), Ph.D.Chief Scientific Officer & Executive DirectorMr. Thomas G. Guiel B.A.Chief Operating OfficerProf. Siamon GordonClinical Director of Inflammation & InfectionDr. Sandy Primrose Ph.D.Technical ConsultantDr. Jayne Green B.Sc., Ph.D.Director of OperationsDr. Alexandre Akoulitchev Ma (Oxon), Ph.D.Chief Scientific Officer & DirectorDr. Steven Tucker M.D., FACPGroup Clinical DirectorDr. Ewan Hunter B.Sc., BSC, Ph.D., Ph.D.(KCL)Chief Data OfficerDr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.Chief Executive Officer & Executive DirectorDr. Ewan Hunter B.Sc., BSC, Ph.D., Ph.D., (KCL)Chief Data OfficerT. DemainCompany Sec.

PNK : OXBOF

Oxford BioDynamics

$0.15

0.05+50.00%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Oxford BioDynamics Plc (OXBOF) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.

Stock Snapshot

0.0016

Prev. Close

3.41M

Market Cap

0.0015

Day Low

-0.31

P/E Ratio

-0.00509

EPS (TTM)

-0.09

Cash Flow per Share

Open

2.13B

Number of Shares

0.0016

Day High

73.71%

Free Float in %

0.04

Book Value

10K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 21, 2026	0.00	0.00	0.00	0.00	1K
Aug 04, 2026	0.00	0.00	0.00	0.00	10K
Jul 06, 2026	0.00	0.00	0.00	0.00	264.84K
Jul 01, 2026	0.00	0.00	0.00	0.00	86.78K
May 27, 2026	0.00	0.00	0.00	0.00	250
Apr 08, 2026	0.00	0.00	0.00	0.00	40K
Apr 07, 2026	0.00	0.00	0.00	0.00	5K
Apr 06, 2026	0.00	0.00	0.00	0.00	357K
Jan 07, 2026	0.00	0.00	0.00	0.00	175.7K
Jan 06, 2026	0.00	0.00	0.00	0.00	130K
Dec 12, 2025	0.00	0.00	0.00	0.00	1K
Nov 13, 2025	0.01	0.01	0.01	0.01	383.33K
Nov 07, 2025	0.00	0.00	0.00	0.00	1K
Oct 28, 2025	0.00	0.01	0.00	0.01	711.11K
Oct 27, 2025	0.01	0.01	0.01	0.01	855.56K
Oct 24, 2025	0.01	0.01	0.01	0.01	367.5K
Oct 20, 2025	0.01	0.01	0.01	0.01	643.33K
Oct 13, 2025	0.01	0.01	0.01	0.01	210K
Oct 10, 2025	0.01	0.01	0.01	0.01	100
Oct 01, 2025	0.01	0.01	0.01	0.01	20K

Contact Details

Oxford, OXF OX4 2WB

United Kingdom

https://www.oxfordbiodynamics.com 441 865 518910

About Company

Headquartered in Oxford, United Kingdom, and established in 2007, Oxford BioDynamics Plc operates as a biotechnology enterprise. The company's primary focus lies in the discovery and development of biomarkers for the pharmaceutical and biotechnology industries, serving both domestic and international markets, with a significant presence in the United States. Central to its operations is EpiSwitch, a proprietary technology platform. This platform facilitates the identification, evaluation, validation, and continuous monitoring of epigenetic biomarkers, specifically referred to as chromosome conformation signatures. These biomarkers are utilized in various applications, including medical testing kits, predicting disease onset or progression, aiding in diagnosis, and informing treatment approaches. Among its innovative products are the EpiSwitch CiRT, a validated prognostic tool for anticipating patient response to checkpoint inhibitor immunotherapy; the EpiSwitch CST, an advanced blood assay designed to forecast the severity of COVID-19 in adult patients; and the EpiSwitch Explorer Array Kit, which enables high-resolution 3D genome profiling and the identification of new biomarkers.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Company Overview

The stock is currently mid-range between its 52-week high and low $0.00 and $0.01. With a market capitalization of about $3.41 million, Oxford BioDynamics Plc is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.15). Key stats such as the average daily volume over the past year has been around 5.94 thousand shares, trading with heavier-than-usual volume. Headquartered in Oxford, OXF, Oxford BioDynamics Plc operates in the Healthcare sector and the Biotechnology industry. Led by CEO Richard Compton, the company employs approximately 51 people and listed since December 30, 2020. Headquartered in Oxford, United Kingdom, and established in 2007, Oxford BioDynamics Plc operates as a biotechnology enterprise.

Valuation Metrics

Oxford BioDynamics Plc trades at a P/E ratio of -0.3, slightly below the S&P 500 average, with a price-to-sales ratio of 2.11 and a price-to-book ratio of 1.38 suggesting the stock is closer to book value. The P/FCF stands at -0.34, also above market averages.

Dividend & Fair Value

Oxford BioDynamics Plc last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.13. This means the shares are trading below this model’s fair value.

Financial & Profitability Overview

Over the trailing twelve months, Oxford BioDynamics generated $1.10M in revenue, or $0.00 per share. Gross margin was -561.55%, operating margin -973.79%, and net profit margin -1018.54%. Returns are negative, with ROA at -137.93% and ROE at -999.37%.
On valuation metrics, Oxford BioDynamics trades at a P/E of -0.30, P/S of 2.11 and P/B of 1.38. The current ratio is 2.01 and quick ratio is 1.89. Operationally, the company’s inventory turnover is 5.35 and cash conversion cycle is 96.83 days. Debt-to-equity is 1.32, supported by a cash flow-to-debt ratio of -1.70.

Quarterly Financial Highlights

For the quarter ended Sep 30, 2025, Oxford BioDynamics posted revenue of $1.10M, down slightly from $510.00K in the prior quarter. Gross profit was - $6.15M (margin -561.55%). Operating income was - $10.66M (margin -973.8%). Net income was- $11.15M (EPS - $0.01).
The company ended the quarter with $1.39M in cash and short-term investments, a total debt of $5.11M, and net debt of $3.72M. Total assets were $8.09M, with equity of $1.12M. Financials further reflected weakness, with operating cash flow of - $7.71M, free cash flow of - $7.73M, and capital expenditures of - $17.00K.

Price Forecast & Outlook

Our AI price prediction model suggests that Oxford BioDynamics Plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Oxford BioDynamics Plc trading at a premium to the broader market with a P/E of -0.3.

Frequently Asked Questions

What is the current Oxford BioDynamics Plc (OXBOF) stock price?

Oxford BioDynamics Plc (OTC: OXBOF) stock price is $0.00 in the last trading session. During the trading session, OXBOF stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in OXBOF stock occurred in the recent session was 0% while the dollar amount for the price change in OXBOF stock was $0.00.

OXBOF's industry and sector of operation?

The OTC listed OXBOF is part of Biotechnology industry that operates in the broader Healthcare sector. Oxford BioDynamics Plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of OXBOF?

Mr. Paul Leslie Stockdale F.C.A., M.A.
Chief Financial Officer & Executive Director
Dr. Alexandre Akoulitchev M.A., Ma (Oxon), Ph.D.
Chief Scientific Officer & Executive Director
Mr. Thomas G. Guiel B.A.
Chief Operating Officer
Prof. Siamon Gordon
Clinical Director of Inflammation & Infection
Dr. Sandy Primrose Ph.D.
Technical Consultant
Dr. Jayne Green B.Sc., Ph.D.
Director of Operations
Dr. Alexandre Akoulitchev Ma (Oxon), Ph.D.
Chief Scientific Officer & Director
Dr. Steven Tucker M.D., FACP
Group Clinical Director
Dr. Ewan Hunter B.Sc., BSC, Ph.D., Ph.D.(KCL)
Chief Data Officer
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.
Chief Executive Officer & Executive Director
Dr. Ewan Hunter B.Sc., BSC, Ph.D., Ph.D., (KCL)
Chief Data Officer
T. Demain
Company Sec.

How OXBOF did perform over past 52-week?

OXBOF's closing price is 1,400% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.01 is -75%.

How many employees does OXBOF have?

Number of OXBOF employees currently stands at 51.

Link for OXBOF official website?

Official Website of OXBOF is: https://www.oxfordbiodynamics.com

How do I contact OXBOF?

OXBOF could be contacted at phone 441 865 518910 and can also be accessed through its website. OXBOF operates from 3140 Rowan Place, Oxford, OXF OX4 2WB, United Kingdom.

How many shares of OXBOF are traded daily?

OXBOF stock volume for the day was 10K shares. The average number of OXBOF shares traded daily for last 3 months was 5.94K.

What is the market cap of OXBOF currently?

The market value of OXBOF currently stands at $3.41M with its latest stock price at $0.00 and 2.13B of its shares outstanding.

Employees	51
Beta	-0.15
Sales or Revenue	$1.10M
5Y Sales Change%	-0.84%
Fiscal Year Ends	September
Sector	Healthcare
Industry	Biotechnology

OXBOF Company Profile and Key Details

Oxford BioDynamics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Price Forecast & Outlook

Dividend & Fair Value

Key Takeaways

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics